We are live on ! Find out more
ACIU icon

AC Immune
ACIU

64 hedge funds and large institutions have $118M invested in AC Immune in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

87% more call options, than puts

Call options by funds: $1.82M | Put options by funds: $976K

17% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 18

12% more funds holding

Funds holding: 57 → 64 (+7)

0.73% less ownership

Funds ownership: 25.04% → 24.31% (-0.73%)

18% less capital invested

Capital invested by funds: $144M → $118M (-$26.2M)

Holders
64
Holders Change
+7
Holders Change %
+12.28%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
21
Reduced
18
Closed
8
Calls
$1.82M
Puts
$976K
Net Calls
+$848K
Net Calls Change
+$270K

Top Buyers

Rank Fund Capital Flow
1
SCM
Suvretta Capital Management
New York
+$6.9M
2
PIM
Platinum Investment Management
Australia
+$4.55M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.38M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$2.84M
5
Morgan Stanley
Morgan Stanley
New York
+$2.06M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$13.6M
2
BI
BVF Inc
California
-$11.5M
3
IC
Ikarian Capital
Texas
-$1.56M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.06M
5
Two Sigma Investments
Two Sigma Investments
New York
-$961K
Name Holding Trade Value Shares
Change 		Change in
Stake
BCV
26
Banque Cantonale Vaudoise
Switzerland
$349K -$141K -19,631 -27%
AWCI
27
Alpine Woods Capital Investors
New York
$336K – – –
Arrowstreet Capital
28
Arrowstreet Capital
Massachusetts
$320K – – –
CSS
29
Cubist Systematic Strategies
Connecticut
$284K +$257K +35,873 +557%
Millennium Management
30
Millennium Management
New York
$271K -$259K -36,117 -47%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$249K – – –
Citadel Advisors
32
Citadel Advisors
Florida
$242K +$102K +14,273 +66%
PVI
33
Pura Vida Investments
New York
$235K +$251K +35,000 New
Goldman Sachs
34
Goldman Sachs
New York
$226K +$2.09K +292 +0.9%
JF
35
Jump Financial
Illinois
$212K +$226K +31,600 New
PP
36
PDT Partners
New York
$195K -$34.4K -4,800 -14%
TD Asset Management
37
TD Asset Management
Ontario, Canada
$194K +$207K +28,900 New
VEA
38
Virtus ETF Advisers
New York
$193K -$10.7K -1,493 -5%
DekaBank Deutsche Girozentrale
39
DekaBank Deutsche Girozentrale
Germany
$182K – – –
ACM
40
ACT Capital Management
Pennsylvania
$144K +$154K +21,500 New
UBS Group
41
UBS Group
Switzerland
$143K +$144K +20,162 +1,749%
Walleye Trading
42
Walleye Trading
New York
$137K +$7.34K +1,026 +5%
ProShare Advisors
43
ProShare Advisors
Maryland
$114K +$28.5K +3,983 +31%
JP Morgan Chase
44
JP Morgan Chase
New York
$109K +$90.8K +12,690 +369%
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$100K -$759 -106 -0.7%
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$91.5K +$97.7K +13,642 New
LBC
47
Lawrence B. Cohen
$86K – – –
Dimensional Fund Advisors
48
Dimensional Fund Advisors
Texas
$85K – – –
CLOS
49
Compagnie Lombard Odier SCmA
Switzerland
$80K – – –
TSS
50
Two Sigma Securities
New York
$76K +$80.7K +11,276 New
1
2
3

ACIU Hedge Fund Activity: Q3 2021 in Review

64 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q3 2021, worth a combined $118M — down 18% from $144M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ACIU positions and 8 closed out — a net gain of 7 holders — while 21 added to existing stakes and 18 trimmed.

The largest buyer was Suvretta Capital Management, opening a new position worth an estimated $6.9M. The largest seller was EcoR1 Capital, cutting an estimated $13.6M.

  • 64 institutional investors held AC Immune (ACIU) as of Q3 2021, up from 57 in Q2 2021.
  • Funds reported $118M of AC Immune stock for Q3 2021, down 18% quarter-over-quarter.
  • 15 funds opened new AC Immune positions in Q3 2021 and 8 closed out, a net change of +7 holders.
  • The largest AC Immune buyer in Q3 2021 was Suvretta Capital Management, an estimated $6.9M added.
  • The largest AC Immune seller in Q3 2021 was EcoR1 Capital, an estimated $13.6M sold.

Based on aggregated 13F filings for Q3 2021.